ZELIRA THERAPEUTICS LIMITED Notification of Consolidation/SplitAnnouncement Summary
Entity name
For personal use only
ZELIRA THERAPEUTICS LIMITED
Applicable security for the reorganisation
ZLD | ORDINARY FULLY PAID |
ZLDAA | OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES |
ZLDAF | PERFORMANCE RIGHTS |
ZLDAL | OPTION EXPIRING 13-NOV-2023 EX $0.07 |
ZLDAG | OPTION EXPIRING 11-SEP-2023 EX 10C |
ZLDAH | OPTION EXPIRING 11-SEP-2023 EX 15C |
ZLDAI | OPTION EXPIRING 11-SEP-2023 EX 20C |
ZLDAJ | OPTION EXPIRING 11-SEP-2023 EX 28C |
ZLDAK | OPTION EXPIRING 11-SEP-2023 EX 30C |
Announcement Type |
Update to previous announcement
Date of this announcement 12/4/2022
Reason for the Update
Shareholder approval for consolidation - received at meeting held 12 April 2022
Refer to below for full details of the announcement
Notification of Consolidation/Split
1 / 7
Notification of Consolidation/SplitAnnouncement Details
For personal use only
Part 1 - Entity and announcement details
1.1 Name of +Entity
ZELIRA THERAPEUTICS LIMITED
1.2 Registered Number Type ABN
1.3 ASX issuer code
ZLD
1.4 The announcement is
Update/amendment to previous announcement
1.4a Reason for update to a previous announcementRegistration Number 27103782378
Shareholder approval for consolidation - received at meeting held 12 April 2022
1.4b Date of previous announcement(s) to this update 14/3/2022
1.5 Date of this announcement 12/4/2022
1.6 Securities affected by the consolidation or splitASX +Security Code ZLD
ASX +Security Description ORDINARY FULLY PAID
ZLDAA
OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
ZLDAF
PERFORMANCE RIGHTS
ZLDAL
OPTION EXPIRING 13-NOV-2023 EX $0.07
ZLDAG
OPTION EXPIRING 11-SEP-2023 EX 10C
ZLDAH
OPTION EXPIRING 11-SEP-2023 EX 15C
Notification of Consolidation/Split
2 / 7
Notification of Consolidation/Split
For personal use only
ZLDAI | OPTION EXPIRING 11-SEP-2023 EX 20C |
ZLDAJ | OPTION EXPIRING 11-SEP-2023 EX 28C |
ZLDAK | OPTION EXPIRING 11-SEP-2023 EX 30C |
Part 2 - Approvals |
2.1 Are any of the below approvals required for the consolidation or split before business day 0 of the timetable?
Security holder approval
Court approval
Lodgement of court order with +ASICACCC approval
FIRB approval
Another approval/condition external to the entity required to be given/met before business day 0 of the timetable for the consolidation or split.
Yes
2.2 Approvals
Approval/Condition +Security holder approval
Date for determination 12/4/2022
Is the date estimated or actual?
Approval received/condition met?
Actual
Yes
Comments
Part 3 - Consolidation or split timetable and details
3.1 +Record date 19/4/2022
3.2 Date of +security holder meeting 12/4/2022
3.2a Effective date of consolidation or split 12/4/2022
3.3 Last day for trading in the pre consolidation or split +securities 13/4/2022
3.4 Trading in the post consolidation or split +securities commences on a deferred settlement basis. 14/4/2022
Notification of Consolidation/Split
3 / 7
Notification of Consolidation/Split
3.5 Record date
19/4/2022
3.6 First day for entity to update its register and to send holding statements to +security holders reflecting the change in the number of +securities they hold.
For personal use only
20/4/2022
3.7 Last day for entity to update its register and send holding statements to +security holders reflecting the change in the number of +securities they hold and to notify ASX that this has occurred. (+Issue Date)
27/4/2022
3.8 Trading starts on a normal T+2 basis 28/4/2022
3.9 First settlement of trades conducted on a +deferred settlement basis and on a normal T+2 basis 2/5/2022
Part 4 - Event type and details
4.1 The event is
+Security consolidation
4.1a Consolidation ratio: the +securities will be consolidated on the basis that every 175
(pre-consolidation) +securities will be consolidated into 1
(post-consolidation) +security (/ies).
4.2 Scrip fraction rounding
Fractions rounded up to the next whole number
Part 5 - +Securities on issue before and after consolidation or split
5.1 +Securities on issue before and after the consolidation or split
ASX +Security Code ZLD
ASX +Security Description ORDINARY FULLY PAID
Quoted/unquotedQuoted
Number on issue pre consolidation or split 1,675,101,964
Number on issue post consolidation or split 9,572,011
Estimate/ActualEstimated
Notification of Consolidation/Split
4 / 7
Notification of Consolidation/Split
ASX +Security Code ZLDAA
ASX +Security Description
OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Quoted/unquotedUnquoted
For personal use only
ASX +Security Code ZLDAF
Quoted/unquotedUnquoted
ASX +Security Code ZLDAL
Quoted/unquotedUnquoted
ASX +Security Code ZLDAG
Quoted/unquotedUnquoted
ASX +Security Code ZLDAH
Quoted/unquotedUnquoted
ASX +Security Code ZLDAI
Quoted/unquotedUnquoted
ASX +Security Code ZLDAJ
Quoted/unquotedUnquoted
Number on issue pre consolidation or split 96,954,338
ASX +Security Description PERFORMANCE RIGHTS
Number on issue pre consolidation or split 393,870,322
ASX +Security Description
Number on issue post consolidation or split 554,025
Number on issue post consolidation or split 2,250,688
OPTION EXPIRING 13-NOV-2023 EX $0.07
Number on issue pre consolidation or split 37,037,000
ASX +Security Description
Number on issue post consolidation or split 211,640
OPTION EXPIRING 11-SEP-2023 EX 10C
Number on issue pre consolidation or split 4,000,000
ASX +Security Description
Number on issue post consolidation or split 22,857
OPTION EXPIRING 11-SEP-2023 EX 15C
Number on issue pre consolidation or split 4,000,000
ASX +Security Description
Number on issue post consolidation or split 22,857
OPTION EXPIRING 11-SEP-2023 EX 20C
Number on issue pre consolidation or split 4,000,000
ASX +Security Description
Number on issue post consolidation or split 22,857
OPTION EXPIRING 11-SEP-2023 EX 28C
Number on issue pre consolidation or split 4,000,000
Number on issue post consolidation or split 22,857
Estimate/ActualEstimatedEstimate/ActualEstimatedEstimate/ActualActualEstimate/ActualActualEstimate/ActualActualEstimate/ActualActualEstimate/ActualActual
ASX +Security Code ZLDAK
ASX +Security Description
OPTION EXPIRING 11-SEP-2023 EX 30C
Quoted/unquoted
Notification of Consolidation/Split
Number on issue pre consolidation or splitNumber on issue post consolidation or splitEstimate/Actual
5 / 7
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Zelda Therapeutics Ltd. published this content on 12 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 April 2022 06:40:09 UTC.
